EMEND

Merck Sharp & Dohme LLC🇺🇸 United States

FDA Page

Effective Date: Dec 1, 2023
Approval ID: 696f9e80-9cae-403b-de9e-078343ce4713
Products: 5 registered
Version: 40

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use EMEND CAPSULES and EMEND FOR ORAL SUSPENSION safely and effectively. See full prescribing information for EMEND CAPSULES and EMEND FOR ORAL SUSPENSION. EMEND (aprepitant) capsules, for oral use EMEND (aprepitant) for oral suspension Initial U.S. Approval: 2003

Quick Stats

Total Products5

Labelers2

Label Sections23

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.